Navigation Links
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Date:9/22/2009

e safety measure of cardiac death or myocardial infarction (MI, commonly referred to as heart attack) remained numerically lower at three years for the TAXUS Liberte Atom Stent as compared to the TAXUS Express Atom Stent (6.5% vs. 7.4%, p=0.79).

"The TAXUS ATLAS Small Vessel Trial showed a sustained and significantly reduced risk of revascularization in small vessels for the TAXUS Liberte Atom Stent as compared to the TAXUS Express Atom Stent out to three years," said Mark A. Turco, M.D., Director of the Center for Cardiac and Vascular Research, Washington Adventist Hospital, and Co-Principal Investigator of the trial. "Positive three-year data from the TAXUS ATLAS Long Lesion Trial showed the TAXUS Liberte Long Stent significantly reduces the risk of MI and cardiac death in long lesions compared to the TAXUS Express Stent, while reporting zero percent stent thrombosis. These data, combined with the previously reported reduction in nine-month late-loss, suggest that these improvements are likely the result of the thinner struts and improved stent geometry of the TAXUS Liberte Stent."

In the TAXUS ATLAS Long Lesion Trial, the TAXUS Liberte Long Stent demonstrated significantly improved safety outcomes when treating long lesions compared to the TAXUS Express Stent. The rate of cardiac death showed a significant 78 percent reduction in patients treated with the TAXUS Liberte Long Stent compared to the TAXUS Express Stent (1.5% vs. 6.7%, p=0.03). Overall MI showed a significant 72 percent reduction at three years in patients receiving a single TAXUS Liberte Long Stent compared to a single TAXUS Express Stent (2.9% vs. 10.4%, p=0.01). This improvement was primarily driven by a significant reduction in non-Q wave MI. The TAXUS Liberte Long Stent had zero stent thrombosis at three years using either the Protocol definition or the ARC definite/probable definition while the control TAXUS Express Stent reported 0.8 percent stent th
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Boston Scientific PROMUS(R) and First-Generation TAXUS(R) Express(R) Stents Continue Excellent Performance in SPIRIT III Trial
2. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
3. SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
4. Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
5. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
6. TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
7. A consistent decline in heart attack rates following the implementation of smoking bans
8. Drug-eluting stents safe, effective for treatment of chronic total occlusions
9. Researchers find drug-eluting stents safe, effective for PCI in diabetics
10. New type of sirolimus-eluting stent demonstrates superior results
11. Sono-Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Raton, FL (PRWEB) , ... July 31, 2015 ... ... marketing and distribution of a wide variety of nutritional and wellness products, announced ... neuromuscular therapist that specializes in massage therapy, active isolated stretching and the prevention ...
(Date:7/31/2015)... ... July 31, 2015 , ... People love to ... disability insurance, where price is an important factor to clients when choosing to ... carrier, offers the Preferred Producer Multi-Life Discount program, where advisers pass savings onto ...
(Date:7/30/2015)... ... ... Dale Sky Jones, Executive Chancellor of Oaksterdam University , the first cannabis ... at the Caribe Royal All Suites Hotel and Convention Center in Orlando, Florida, October ... medical cannabis expo in the country and this year’s expo will be the first ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Committed to ... to action by asking community members to contribute to the College’s “My Brother’s Keeper ... of our young people stay on track. Providing the support they need to think ...
(Date:7/30/2015)... ... ... OSF Healthcare System has been recognized as one of the nation’s ... & Health Networks. This marks the fourth consecutive year for this achievement by the ... Third Order of St. Francis . , Health data security and patient engagement are ...
Breaking Medicine News(10 mins):Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... Wellness through Education and Research InitiativesNEW YORK, April ... as a leadership contributor with the National Thoroughbred ... partnership,s aim is to ensure the health and ... accreditation program are addressed in a manner that ...
... Attention to Connecticut,s Growing Burden of Chronic Disease and Promote ... by CrisisHARTFORD, Conn., April 6 National and state health ... launch a Partnership to call for comprehensive health and economic ... in Connecticut and across the nation. , , ...
... Studies will chart recovery of active women with breast ... -- A Yale professor has received $7 million in ... ovarian and breast cancer recovery. , The U.S. ... that exercise along with traditional courses of treatment can ...
... identifies a protein that modifies the androgen receptor (AR) and ... progression of prostate cancer. The research, published by Cell Press ... Cell , may also drive creation of new strategies for ... to traditional anti-hormone therapies. , The AR is an ...
... joke that gets all the laughs. As funny as folks ... That,s one conclusion of a groundbreaking new paper from the ... the University of Toronto,s Rotman School of Management and the ... authors looked at the effect of sexual behavior in the ...
... is sweeping the countryCORDOVA, Tenn., April 6 Christian Companion ... practical and spiritual assistance, is opening an office in Cordova, ... The new office is located at 1160 Vickery Lane, Suite ... 1:30 p.m. and will last until 3:30 p.m. Free refreshments ...
Cached Medicine News:Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 2Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 3Health News:Bipartisan CT Coalition Forms to Fight Spiraling Health Care Costs 2Health News:Yale Plans Closer Look at Exercise and Cancer 2Health News:A potential new target for treatment of hormone refractory prostate cancer 2
(Date:7/30/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ) ... Canaccord Genuity 35th Annual Growth Conference on Wednesday, August ... Boston Hotel.  A webcast of the ... are encouraged to visit the web site at least ... to register, download and install any necessary software.  The ...
(Date:7/30/2015)... , July 30, 2015  Cleave Biosciences ... Trademark Office has granted the company a key ... Cleave,s lead molecule CB-5083. This newly ... inhibitors of p97," U.S. 9,062,026, allows for claims ... first-in-class, highly selective oral inhibitor of p97, a ...
(Date:7/30/2015)... 30, 2015 Flexpoint Ford, a private equity ... today announced that it has entered into a partnership ... to form Kastle Therapeutics, LLC (Kastle).  The new ... focus on acquiring, developing and commercializing pharmaceuticals targeted toward ... include select therapies already approved for marketing, as well ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... Alsius Corporation,(Nasdaq: ALUS ), the worldwide leader ... four scientific,posters featuring both patient cases and laboratory ... be presented this week at the American,Society of ... Dr. Arie Blitz, Director of Heart Transplantation ...
... Trial Results Disclosed, SAN DIEGO, Oct. ... developing "Best-in-Class" drugs for the,treatment of serious ... multiple studies on its lead program, TR-701, ... in eighteen presentations at the upcoming joint,Interscience ...
Cached Medicine Technology:Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 2Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 3Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 2Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: